An abstract from the American Heart Association's Scientific Sessions 2026 reveals the continuous expansion of the GLP-1 medication class.
|Articles|January 27, 2023
News Roundup: January 23 to January 27
Author(s)Meg Marzella
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
Breaking: FDA Committee Votes in Favor of New, Unified COVID-19 Vaccine Strategy
Recommendations from the unanimous vote must be adopted by the FDA and CDC.
Navigating and Treating 'New Year Depression' in Patients
There may not be a diagnosis for ‘New Year Depression,’ but about 10% to 20% of individuals in the US may get a milder form of these winter blues.
Smart Injector Insulin Pen Device, Mallya, Cleared by FDA
Mallya can provide convenience for insulin pen users; however, it has yet to be released in the United States.
2a Trial of Psychedelic for Major Depressive Disorder Shows Positive Results
SPL026 with supportive therapy sees positive results in patients with major depressive disorder.
For the First Time Medicaid Net Drug Spending Hits Double-Digits
Spending on specialty drugs fueled a 11% increase in Medicaid drug spending from 2020 to 2021, says Magellan's seventh annual Medicaid Pharmacy Trend Report.
Advertisement
Related to this article
Matthew Crawford, PhD, of the University of Virginia, and Mario Danek of Qnovia explain what pharmacists can do now and what may come next.
The inquiry puts audit practices, including how pharmacies are selected for audit, proportionality, and pharmacy advocacy in focus.
Nolla Derm’s overseeing physician, Zaid Fadul, MD, FS, FAAFP, discusses the revolutionary AI technology that could transform how health care conducts prescribing practices.
As COVID-19 vaccine guidance shifts, new data suggest vaccinated patients face no greater clot or death risk than with other respiratory infections.
Alyssa Eisenberg, PharmD, explores technology’s emerging role in the health care environment and how the pharmacist of the future’s day-to-day tasks might evolve.
In the final portion of our discussion with Kimberly Kue-Tsemo, PharmD, she explores the key developments that could be the most significant push toward reducing pharmacy deserts.
In the second part of our interview with a collection of pharmacists from various backgrounds, they delve into the current developments highlighting the future of the profession.
Advertisement
Advertisement
Trending on Drug Topics
1
PBMs Must Now Disclose Fees to Employer Plans Under Final DOL Rule
2
PBM Audit Practices Under Scrutiny: What the House Inquiry Means for Independent Pharmacies
3
COVID-19 Vaccine Lowers Venous Thromboembolism, Mortality Risk
4
GLP-1s Outperform Metformin in Prediabetes Risk, MACE
5